Overview
Chi Cheung is a primary care provider, practicing in Internal Medicine in Adams, Massachusetts. Dr. Cheung is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Ringworm, Infant Hyperglycemia, Diabetic Neuropathy, and Hypertension. Dr. Cheung is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2 Park St, Adams, MA 01220
Dartmouth-Hitchcock Clinic
Haris Bilal is a primary care provider, practicing in Internal Medicine in Keene, New Hampshire. Dr. Bilal is rated as an Advanced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Mcleod Neuroacanthocytosis Syndrome, Huntington Disease, Familial Neurocardiogenic Syncope, Endoscopy, and Pacemaker Implantation.
Ch Specialty Services Ma PC
Adekunle Fajana is a primary care provider, practicing in Internal Medicine in Springfield, Massachusetts. Dr. Fajana is rated as an Advanced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are End-Stage Renal Disease (ESRD), Neurotoxicity Syndromes, Delirium, and Necrotizing Myopathy (NM).
Mattthew Guiltinan is a primary care provider, practicing in Internal Medicine in Keene, New Hampshire. Dr. Guiltinan is rated as an Advanced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Neurotoxicity Syndromes, Colonoscopy, and Endoscopy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Diabetic NeuropathyDr. Cheung isDistinguished. Learn about Diabetic Neuropathy.
- Infant HyperglycemiaDr. Cheung isDistinguished. Learn about Infant Hyperglycemia.
- RingwormDr. Cheung isDistinguished. Learn about Ringworm.
- Advanced
- Alzheimer's DiseaseDr. Cheung isAdvanced. Learn about Alzheimer's Disease.
- AnemiaDr. Cheung isAdvanced. Learn about Anemia.
- AtherosclerosisDr. Cheung isAdvanced. Learn about Atherosclerosis.
- Chronic CoughDr. Cheung isAdvanced. Learn about Chronic Cough.
- Chronic Obstructive Pulmonary Disease (COPD)
- Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
- Experienced
- ActinomycosisDr. Cheung isExperienced. Learn about Actinomycosis.
- Acute Kidney FailureDr. Cheung isExperienced. Learn about Acute Kidney Failure.
- Acute Mountain SicknessDr. Cheung isExperienced. Learn about Acute Mountain Sickness.
- Acute PancreatitisDr. Cheung isExperienced. Learn about Acute Pancreatitis.
- Alcoholic NeuropathyDr. Cheung isExperienced. Learn about Alcoholic Neuropathy.
- ALK-Positive Non-Small Cell Lung CancerDr. Cheung isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.